A Synthetic Liposome Nanoparticle Vaccine Platform for Broad-Spectrum Vaccine Design
Nano Letters · 2025
DOI: 10.1021/acs.nanolett.5c03021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Mo Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China. Hauptthemen laut MEDLINE: Liposomes, Nanoparticles, COVID-19 Vaccines, SARS-CoV-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Key Research and Development Program of China, CAMS Innovation Fund for Medical Sciences, Jilin University Science and Technology Innovative Research Team.
Abstract (Originalsprache)
Emerging viruses such as SARS-CoV-2 and HIV-1 pose major challenges for traditional vaccines due to their rapid mutation and immune evasion. Here, we present a modular liposomal nanoparticle (LNP) vaccine platform integrating trimeric immunogens and synergistic adjuvants to induce broad and durable immunity. Using a self-assembled SARS-CoV-2 RBD trimer (RM) based on MTQ and Ni 2+ /His-tag coupling, antigens were directionally displayed on LNPs coloaded with QS-21, MPLA, and R848 adjuvants. This RM-LNP formulation enhanced antigen stability, lymph node targeting, and germinal center responses, eliciting high titers of broadly neutralizing antibodies and strong T and memory B cell immunity. The RM-LNP vaccine conferred potent neutralization against Omicron subvariants and protected hACE2 mice from Delta, BA.5, and XBB infection. Extension to HIV-1 vaccine design also demonstrated significant and broad neutralization against Tier 2 strains. This study offers a versatile nanovaccine strategy for combating highly mutable viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, State Key Laboratory of Pathogen and Biosecurity, Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Research Unit of…
- Shanghai Pudong Hospital, Fudan University Pudong Medical Center, School of Life Sciences, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200438, China.
- Key Laboratory for Molecular Enzymology and Engineering, the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.
ORCID-Profile: Bin Yu
Förderung
- National Key Research and Development Program of China
- CAMS Innovation Fund for Medical Sciences
- Jilin University Science and Technology Innovative Research Team
- Program for Jilin University Science and Technology Innovative Research Team
- “Medicine + X” Interdisciplinary Innovation Team of Norman Bethune Health Science Center of Jilin University
Zitieren
APA
Zhang, M., Gao, Z., Feng, S., Wang, X., Wang, H., Yang, C., Lin, X., Xu, Z., Zhang, N., Li, Y., Tian, H., Jin, N., Yu, B., Wang, P., Li, C., & Yu, X. (2025). A Synthetic Liposome Nanoparticle Vaccine Platform for Broad-Spectrum Vaccine Design. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c03021
Vancouver
Zhang M, Gao Z, Feng S, Wang X, Wang H, Yang C, et al. A Synthetic Liposome Nanoparticle Vaccine Platform for Broad-Spectrum Vaccine Design. Nano Letters. 2025. doi:10.1021/acs.nanolett.5c03021
BibTeX
@article{Zhang2025,
author = {Zhang, Mo and Gao, Zihan and Feng, Sheng and Wang, Xun and Wang, Huaiyu and Yang, Chumeng and Lin, Xiaolei and Xu, Zhiqiang and Zhang, Nan and Li, Yiyang and Tian, Haochen and Jin, Ningyi and Yu, Bin and Wang, Pengfei and Li, Chang and Yu, Xianghui},
title = {A Synthetic Liposome Nanoparticle Vaccine Platform for Broad-Spectrum Vaccine Design},
journal = {Nano Letters},
year = {2025},
doi = {10.1021/acs.nanolett.5c03021}
}
EUVIMED